Literature DB >> 4834485

Activated prothrombin concentrate for patients with factor VIII inhibitors.

E M Kurczynski, J A Penner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4834485     DOI： 10.1056/NEJM197407252910402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Prothrombin complex concentrate: use in controlling the hemorrhagic diathesis of chronic liver disease.

Authors:  R L Bick; W R Schmalhorst; E Shanbrom
Journal:  Am J Dig Dis       Date:  1975-08

Review 2.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

3.  Successful treatment with prothrombin complex concentrate of postoperative bleeding in a haemophiliac with a factor VIII inhibitor.

Authors:  G D Lowe; A Harvie; C D Forbes; C R Prentice
Journal:  Br Med J       Date:  1976-11-06

4.  Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.

Authors:  K M Brinkhous; U Hedner; J B Garris; V Diness; M S Read
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  The history of haemophilia.

Authors:  G I Ingram
Journal:  J Clin Pathol       Date:  1976-06       Impact factor: 3.411

6.  Plasma exchange in non-haemophiliac patients with inhibitors to factor VIIIC.

Authors:  J G Erskine; A K Burnett; I D Walker; J F Davidson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-19

7.  Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.

Authors:  D H Parry; A L Bloom
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

8.  Factor VIII inhibitors in hemophilia A: rationale and latest evidence.

Authors:  Char Witmer; Guy Young
Journal:  Ther Adv Hematol       Date:  2013-02

9.  Clinical use of blood, blood components and blood products.

Authors:  M A Blajchman; F A Shepherd; R A Perrault
Journal:  Can Med Assoc J       Date:  1979-07-07       Impact factor: 8.262

10.  Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors.

Authors:  R T Wensley; R F Stevens; A M Burn; I W Delamore
Journal:  Br Med J       Date:  1980-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.